The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy
Abstract
The nonobese diabetic (NOD) mouse is an excellent model of insulin-dependent (type I) human diabetes mellitus. We report that a single injection of complete Freund's adjuvant (CFA) given at an early age (5 wk) prevented the appearance of diabetes and greatly increased the life span of NOD mice without additional therapy. No treated mouse developed hyperglycemia by the age of 12 mo (n = 13), whereas all untreated mice died of diabetes before 8 mo of age (n = 38). All CFA-treated mice were alive and healthy at 12 mo of age. Some CFA-treated NOD mice that were monitored for long-term survival are still alive with no sign of disease at 18 mo of age (n = 5). Administration of CFA resulted in decreased in vitro splenic lymphocyte proliferative responses to alloantigen and mitogen. Cell-mixing experiments indicated that antigen-nonspecific inhibitory cells were elicited in the spleen and increased in the bone marrow. These regulatory cells were Thy-1− ; and nonadherent to nylon wool, as has been described for natural suppressor (NS) cells. These data lend support to a relationship between the boosting of endogenous NS activity and the establishment of tolerance to self in the context of autoimmunity. Our results suggest that early nonspecific immunotherapy of genetically predisposed individuals could prevent the development of autoimmune diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breeding of a Non-Obese, Diabetic Strain of Mice
MAKINO, S., KUNIMOTO, K., MURAOKA, Y., MIZUSHIMA, Y., KATAGIRI, K., & TOCHINO, Y. (1980) · Experimental Animals · doi:10.1538/expanim1978.29.1_1 · Cited by 1,249
Bendelac, A., Carnaud, C., Boitard, C., & Bach, J. F. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.823 · Cited by 569
Rammensee, H.-G., Kroschewski, R., & Frangoulis, B. (1989) · Nature · doi:10.1038/339541a0 · Cited by 449
The NOD Mouse: Recessive Diabetogenic Gene in the Major Histocompatibility Complex
Hattori, M., Buse, J. B., Jackson, R. A., Glimcher, L., Dorf, M. E., Minami, M., Makino, S., Moriwaki, K., Kuzuya, H., Imura, H., et al. (1986) · Science · doi:10.1126/science.3003909 · Cited by 418
Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice
Wicker, L. S., Miller, B. J., & Mullen, Y. (1986) · Diabetes · doi:10.2337/diab.35.8.855 · Cited by 381
Miyazaki, A., Hanafusa, T., Yamada, K., Miyagawa, J., Fujino-Kurihara, H., Nakajima, H., Nonaka, K., & Tarui, S. (1985) · PubMed Central · Cited by 235
Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.
Wicker, L. S., Miller, B. J., Coker, L. Z., McNally, S. E., Scott, S., Mullen, Y., & Appel, M. C. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.6.1639 · Cited by 226
Strober, S. (1984) · Annual Review of Immunology · doi:10.1146/annurev.iy.02.040184.001251 · Cited by 222
Preventive Effect of Monoclonal Anti-L3T4 Antibody on Development of Diabetes in NOD Mice
Koike, T., Itoh, Y., Ishii, T., Ito, I., Takabayashi, K., Maruyama, N., Tomioka, H., & Yoshida, S. (1987) · Diabetes · doi:10.2337/diab.36.4.539 · Cited by 213
Islet Allograft Survival After a Single Course of Treatment of Recipient with Antibody to L3T4
Shizuru, J. A., Gregory, A. K., Chao, C. T.-B., & Fathman, C. G. (1987) · Science · doi:10.1126/science.2955518 · Cited by 171
Cited by
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921
Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025792 · Cited by 778
Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity
King, C., Ilic, A., Koelsch, K., & Sarvetnick, N. (2004) · Cell · doi:10.1016/s0092-8674(04)00335-6 · Cited by 670
Metadata
- Authors
- Sadelain, M. W. J., Qin, H.-Y., Lauzon, J., & Singh, B.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1990-05-01
- Volume
- 39
- Issue
- 5
- Pages
- 583-589
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2162459661
- Cited by
- 275
- References
- 15
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy. https://app.cochat.ai/papers/10.2337/diab.39.5.583
- The paper
- Sadelain, M. W. J., Qin, H.-Y., Lauzon, J., & Singh, B. (1990). Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy. Diabetes. https://doi.org/10.2337/diab.39.5.583
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.